Related Experiment Video
Updated: May 29, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Late-type vitamin K deficiency bleeding: experience from 120 patients
Mehmet Akif Ozdemir1, Musa Karakukcu, Huseyin Per
1Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Erciyes University, Talas, Kayseri, Turkey.
Late vitamin K deficiency bleeding (VKDB) in infants can cause severe intracranial hemorrhages. Routine vitamin K prophylaxis at birth is crucial for preventing this serious condition and its associated mortality.
Area of Science:
- Pediatrics
- Neonatology
- Hematology
Background:
- Vitamin K deficiency bleeding (VKDB) predisposes infants to early, classic, or late forms.
- Late VKDB, occurring in exclusively breastfed infants aged 2-24 weeks, is a significant cause of intracranial bleeding, mortality, and morbidity in developing countries.
Purpose of the Study:
- To evaluate the clinical characteristics, management, and outcomes of late vitamin K deficiency bleeding (VKDB) in infants.
- To emphasize the importance of vitamin K prophylaxis in preventing severe hemorrhagic complications.
Main Methods:
- A retrospective review of 120 infants diagnosed with late VKDB between June 1990 and June 2006.
- Evaluation of clinical signs, symptoms, treatments, hemorrhage types, and mortality rates.
Main Results:
- Intracranial hemorrhage occurred in 73% of patients, with various types including subdural, intracerebral, and intraventricular.
- Common symptoms included bulging fontanels (70%), irritability (50%), and convulsions (49%).
- The mortality rate was 31%.
Conclusions:
- Late VKDB is associated with significant morbidity and mortality.
- Administration of 1 mg of vitamin K at birth can effectively prevent intracranial bleeding and other hemorrhagic manifestations, thus avoiding late VKDB.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Vitamins
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...